These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38965553)

  • 1. Exosome for mRNA delivery: strategies and therapeutic applications.
    Iqbal Z; Rehman K; Mahmood A; Shabbir M; Liang Y; Duan L; Zeng H
    J Nanobiotechnology; 2024 Jul; 22(1):395. PubMed ID: 38965553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes for mRNA delivery: a novel biotherapeutic strategy with hurdles and hope.
    Aslan C; Kiaie SH; Zolbanin NM; Lotfinejad P; Ramezani R; Kashanchi F; Jafari R
    BMC Biotechnol; 2021 Mar; 21(1):20. PubMed ID: 33691652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
    Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosome engineering for efficient and targeted drug delivery: Current status and future perspective.
    Malekian F; Shamsian A; Kodam SP; Ullah M
    J Physiol; 2023 Nov; 601(22):4853-4872. PubMed ID: 35570717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy.
    Li J; Zhang Y; Dong PY; Yang GM; Gurunathan S
    Biomed Pharmacother; 2023 Sep; 165():115087. PubMed ID: 37392659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in exosome therapies in ophthalmology-From bench to clinical trial.
    Sanghani A; Andriesei P; Kafetzis KN; Tagalakis AD; Yu-Wai-Man C
    Acta Ophthalmol; 2022 May; 100(3):243-252. PubMed ID: 34114746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome-mediated mRNA delivery in vivo is safe and can be used to induce SARS-CoV-2 immunity.
    Tsai SJ; Atai NA; Cacciottolo M; Nice J; Salehi A; Guo C; Sedgwick A; Kanagavelu S; Gould SJ
    J Biol Chem; 2021 Nov; 297(5):101266. PubMed ID: 34600888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
    Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
    J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Strategies for Exosome Cargo Loading and Targeting Delivery.
    Zeng H; Guo S; Ren X; Wu Z; Liu S; Yao X
    Cells; 2023 May; 12(10):. PubMed ID: 37408250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosome as a Novel Shuttle for Delivery of Therapeutics across Biological Barriers.
    Das CK; Jena BC; Banerjee I; Das S; Parekh A; Bhutia SK; Mandal M
    Mol Pharm; 2019 Jan; 16(1):24-40. PubMed ID: 30513203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex Coacervates as a Promising Vehicle for mRNA Delivery: A Comprehensive Review of Recent Advances and Challenges.
    Forenzo C; Larsen J
    Mol Pharm; 2023 Sep; 20(9):4387-4403. PubMed ID: 37561647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises.
    Rezakhani L; Kelishadrokhi AF; Soleimanizadeh A; Rahmati S
    Chem Phys Lipids; 2021 Jan; 234():105009. PubMed ID: 33189639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the clinical transition of engineered exosomes designed for intracellular delivery of therapeutic proteins.
    Kim M; Choi H; Jang DJ; Kim HJ; Sub Y; Gee HY; Choi C
    Stem Cells Transl Med; 2024 Jul; 13(7):637-647. PubMed ID: 38838263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications.
    Tian J; Han Z; Song D; Peng Y; Xiong M; Chen Z; Duan S; Zhang L
    Int J Nanomedicine; 2023; 18():7923-7940. PubMed ID: 38152837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering exosomes for targeted drug delivery.
    Liang Y; Duan L; Lu J; Xia J
    Theranostics; 2021; 11(7):3183-3195. PubMed ID: 33537081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive review of engineered exosomes from the preparation strategy to therapeutic applications.
    Fan X; Zhang Y; Liu W; Shao M; Gong Y; Wang T; Xue S; Nian R
    Biomater Sci; 2024 Jul; 12(14):3500-3521. PubMed ID: 38828621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome-mediated delivery of inflammation-responsive
    Bu T; Li Z; Hou Y; Sun W; Zhang R; Zhao L; Wei M; Yang G; Yuan L
    Theranostics; 2021; 11(20):9988-10000. PubMed ID: 34815799
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent advances in exosome-mediated nucleic acid delivery for cancer therapy.
    Zhang Y; Liu Q; Zhang X; Huang H; Tang S; Chai Y; Xu Z; Li M; Chen X; Liu J; Yang C
    J Nanobiotechnology; 2022 Jun; 20(1):279. PubMed ID: 35701788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review.
    Chen Z; Xiong M; Tian J; Song D; Duan S; Zhang L
    J Nanobiotechnology; 2024 Jan; 22(1):18. PubMed ID: 38172932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosome-Mediated Targeted Delivery of miRNAs.
    Ohno S; Kuroda M
    Methods Mol Biol; 2016; 1448():261-70. PubMed ID: 27317187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.